- Home
- VNRX vs RPTX Comparison
VNRX vs RPTX Comparison
Compare VNRX & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- RPTX
- Stock Information
- Founded
- VNRX N/A
- RPTX 2016
- Country
- VNRX United States
- RPTX Canada
- Employees
- VNRX N/A
- RPTX N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- RPTX Health Care
- Exchange
- VNRX Nasdaq
- RPTX Nasdaq
- Market Cap
- VNRX 68.3M
- RPTX 69.2M
- IPO Year
- VNRX N/A
- RPTX 2020
- Fundamental
- Price
- VNRX $0.60
- RPTX $1.69
- Analyst Decision
- VNRX Strong Buy
- RPTX Strong Buy
- Analyst Count
- VNRX 4
- RPTX 3
- Target Price
- VNRX $3.50
- RPTX $4.50
- AVG Volume (30 Days)
- VNRX 196.8K
- RPTX 91.2K
- Earning Date
- VNRX 08-14-2025
- RPTX 08-08-2025
- Dividend Yield
- VNRX N/A
- RPTX N/A
- EPS Growth
- VNRX N/A
- RPTX N/A
- EPS
- VNRX N/A
- RPTX N/A
- Revenue
- VNRX $1,319,252.00
- RPTX $250,000.00
- Revenue This Year
- VNRX $274.46
- RPTX N/A
- Revenue Next Year
- VNRX $212.60
- RPTX N/A
- P/E Ratio
- VNRX N/A
- RPTX N/A
- Revenue Growth
- VNRX 35.10
- RPTX N/A
- 52 Week Low
- VNRX $0.40
- RPTX $0.89
- 52 Week High
- VNRX $0.94
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- VNRX 39.24
- RPTX 66.56
- Support Level
- VNRX $0.64
- RPTX $1.66
- Resistance Level
- VNRX $0.73
- RPTX $1.60
- Average True Range (ATR)
- VNRX 0.04
- RPTX 0.06
- MACD
- VNRX -0.00
- RPTX 0.01
- Stochastic Oscillator
- VNRX 19.34
- RPTX 80.95
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.